133 related articles for article (PubMed ID: 10940688)
1. Natural history of neuroendocrine enteropancreatic tumors.
Mignon M
Digestion; 2000; 62 Suppl 1():51-8. PubMed ID: 10940688
[TBL] [Abstract][Full Text] [Related]
2. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
[TBL] [Abstract][Full Text] [Related]
3. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
Swarts DR; Ramaekers FC; Speel EJ
Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
[TBL] [Abstract][Full Text] [Related]
4. Statistical evaluation of 2001 carcinoid cases with metastases, collected from literature: a comparative study between ordinary carcinoids and atypical varieties.
Soga J
J Exp Clin Cancer Res; 1998 Mar; 17(1):3-12. PubMed ID: 9646227
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity.
Garbrecht N; Anlauf M; Schmitt A; Henopp T; Sipos B; Raffel A; Eisenberger CF; Knoefel WT; Pavel M; Fottner C; Musholt TJ; Rinke A; Arnold R; Berndt U; Plöckinger U; Wiedenmann B; Moch H; Heitz PU; Komminoth P; Perren A; Klöppel G
Endocr Relat Cancer; 2008 Mar; 15(1):229-41. PubMed ID: 18310290
[TBL] [Abstract][Full Text] [Related]
6. PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors.
Long KB; Srivastava A; Hirsch MS; Hornick JL
Am J Surg Pathol; 2010 May; 34(5):723-9. PubMed ID: 20414099
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
D'Adda T; Keller G; Bordi C; Höfler H
Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509
[TBL] [Abstract][Full Text] [Related]
8. Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors.
Klöppel G; Rindi G; Anlauf M; Perren A; Komminoth P
Virchows Arch; 2007 Aug; 451 Suppl 1():S9-27. PubMed ID: 17684761
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine tumors of the gastrointestinal tract.
Chejfec G; Falkmer S; Askensten U; Grimelius L; Gould VE
Pathol Res Pract; 1988 Apr; 183(2):143-54. PubMed ID: 3290866
[TBL] [Abstract][Full Text] [Related]
10. A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor Progression.
Fahrmann JF; Wasylishen AR; Pieterman CRC; Irajizad E; Vykoukal J; Murage E; Wu R; Dennison JB; Krishna H; Peterson CB; Lozano G; Zhao H; Do KA; Halperin DM; Agarwal SK; Blau JE; Del Rivero J; Nilubol N; Walter MF; Welch JM; Weinstein LS; Vriens MR; van Leeuwaarde RS; van Treijen MJC; Valk GD; Perrier ND; Hanash SM
J Clin Endocrinol Metab; 2021 Nov; 106(12):e4969-e4980. PubMed ID: 34318891
[TBL] [Abstract][Full Text] [Related]
11. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
12. [Neuroendocrine neoplasms of the mediastinum].
Brcic L; Heidinger M; Popper H
Pathologe; 2016 Sep; 37(5):434-40. PubMed ID: 27507161
[TBL] [Abstract][Full Text] [Related]
13. [Proposal for a TNM classification of digestive (neuro)endocrine tumors: recommendations of the European Neuroendocrine Tumor Society (2006)].
Couvelard A; Scoazec JY
Ann Pathol; 2006 Dec; 26(6):413-7. PubMed ID: 17255899
[No Abstract] [Full Text] [Related]
14. Carcinoid tumors.
Robertson RG; Geiger WJ; Davis NB
Am Fam Physician; 2006 Aug; 74(3):429-34. PubMed ID: 16913162
[TBL] [Abstract][Full Text] [Related]
15. Carcinoid tumors: development of our knowledge.
Creutzfeldt W
World J Surg; 1996 Feb; 20(2):126-31. PubMed ID: 8661807
[TBL] [Abstract][Full Text] [Related]
16. Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life.
Gonçalves TD; Toledo RA; Sekiya T; Matuguma SE; Maluf Filho F; Rocha MS; Siqueira SA; Glezer A; Bronstein MD; Pereira MA; Jureidini R; Bacchella T; Machado MC; Toledo SP; Lourenço DM
J Clin Endocrinol Metab; 2014 Jan; 99(1):E89-96. PubMed ID: 24178797
[TBL] [Abstract][Full Text] [Related]
17. Metastasectomy of neuroendocrine tumors in patients with multiple endocrine neoplasia type 1.
Dy BM; Que FG; Thompson GB; Young WF; Rowse P; Strajina V; Richards ML
Am J Surg; 2014 Dec; 208(6):1047-53; discussion 1052-3. PubMed ID: 25440487
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal carcinoid tumours. Histogenetic, histochemical, immunohistochemical, clinical and therapeutic aspects.
Wilander E; Lundqvist M; Oberg K
Prog Histochem Cytochem; 1989; 19(2):1-88. PubMed ID: 2662260
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine neoplasms of the larynx: an overview.
Ferlito A; Silver CE; Bradford CR; Rinaldo A
Head Neck; 2009 Dec; 31(12):1634-46. PubMed ID: 19536850
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
